SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 85 filers reported holding SEELOS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $114,322 | -67.6% | 621,317 | +110.5% | 0.03% | -69.3% |
| Q2 2023 | $352,766 | +27.9% | 295,202 | -26.0% | 0.10% | +17.4% |
| Q1 2023 | $275,881 | +8.9% | 399,133 | +7.0% | 0.09% | +21.1% |
| Q4 2022 | $253,323 | -47.7% | 373,083 | -20.6% | 0.07% | -45.8% |
| Q3 2022 | $484,000 | +95.2% | 470,151 | +29.0% | 0.13% | +89.9% |
| Q2 2022 | $248,000 | -17.6% | 364,597 | +1.6% | 0.07% | +38.0% |
| Q1 2022 | $301,000 | -6.2% | 358,796 | +82.4% | 0.05% | +28.2% |
| Q4 2021 | $321,000 | +156.8% | 196,677 | +280.0% | 0.04% | +95.0% |
| Q3 2021 | $125,000 | – | 51,760 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,500,000 | $4,075,000 | 1.71% |
| Connacht Asset Management LP | 498,925 | $813,000 | 0.79% |
| GENDELL JEFFREY L | 2,449,267 | $3,992,000 | 0.32% |
| MANGROVE PARTNERS IM, LLC | 2,133,436 | $3,478,000 | 0.21% |
| Uniplan Investment Counsel, Inc. | 1,550,359 | $2,527,000 | 0.14% |
| Financial Advocates Investment Management | 24,673 | $1,994,000 | 0.13% |
| Connacht Asset Management LP | 72,300 | $118,000 | 0.12% |
| Woodline Partners LP | 4,047,231 | $6,597,000 | 0.09% |
| 1492 Capital Management LLC | 108,286 | $177,000 | 0.09% |
| Ikarian Capital, LLC | 244,171 | $398,000 | 0.06% |